Coherus Oncology, Inc.
Recent Filings
All 887 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| 10-K | 10-K | Mar 9, 2026 |
| 8-K | 8-K | Mar 9, 2026 |
| 8-K | 8-K | Feb 17, 2026 |
| 424B5 | 424B5 | Feb 13, 2026 |
| 424B5 | 424B5 | Feb 12, 2026 |
| SCHEDULE 13G | — | Feb 5, 2026 |
| 8-K | 8-K | Feb 4, 2026 |
| SCHEDULE 13G/A | — | Jan 30, 2026 |
| 4 | — | Jan 26, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Wahlstrom Mats | — | Sale | 99,988 @ $0.74 | — | May 23, 2025 |
| Lanfear Dennis M | President & CEO | Award / Grant | 86,250 | 654,853 | Jan 20, 2023 |
| McMichael Bryan J | See Remarks | Award / Grant | 12,500 | 26,386 | Jan 20, 2023 |
| Vexler Vladimir | Chief Scientific Officer | Award / Grant | 40,000 | 131,323 | Jan 20, 2023 |
| Stilwell McDavid | Chief Financial Officer | Award / Grant | 40,000 | 104,243 | Jan 20, 2023 |
| Wahlstrom Mats | — | Award / Grant | 29,994 @ $2.08 | 40,000 | Feb 25, 2022 |
| Lanfear Dennis M | President & CEO | Award / Grant | 86,250 | 579,508 | Jan 4, 2022 |
| Stilwell McDavid | Chief Financial Officer | Award / Grant | 40,000 | 73,138 | Jan 4, 2022 |
| Vexler Vladimir | Chief Scientific Officer | Award / Grant | 40,000 | 115,154 | Jan 4, 2022 |
| Stilwell McDavid | Chief Financial Officer | Sale | 3,507 @ $16.80 | 31,611 | Oct 15, 2021 |